Oxford Biomedica Banner Image

Oxford Biomedica

  • Ticker OXB
    Exchange LSE More
  • Industry Biotechnology More
  • Sector Healthcare More
Oxford Biomedica Logo Image
  • 201-500 Employees
  • Based in Oxford, England
Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy company focused on developing life-changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the “Group”) have built a sector leading lentiviral vector delivery platform (LentiVector®) through which the Group develops in vivo and ex-vivo products both in-house and with partners. The Group has created aMore valuable proprietary portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders.
4.8 / 5.0 (65)

Oxford Biomedica reports have an aggregate usefulness score of 4.8 based on 65 reviews.

Oxford Biomedica

Most Recent Annual Report

Oxford Biomedica
MOST RECENT 2022 Annual Report

Oxford Biomedica does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Oxford Biomedica Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!